Frontiers in immunology

Lactobacillus plantarum JYLP-326 may reduce anxiety, depression, and insomnia in anxious college students by changing gut bacteria and metabolism

Updated

Abstract

JYLP-326 may alleviate anxiety, depression, and insomnia in test anxious college students.

  • Sixty anxious students participated, with random allocation to a probiotic group or placebo group over three weeks.
  • Questionnaire results indicated improvements in anxiety, depression, and insomnia symptoms among those taking JYLP-326.
  • The placebo group exhibited a greater diversity index in gut microbiomes compared to a control group.
  • JYLP-326 administration was associated with changes in gut microbiota, including increased abundance of certain beneficial bacteria.
  • Test anxiety correlated with specific alterations in fecal metabolites, which may be normalized following JYLP-326 intake.

Simplified

Key numbers

7.63 ± 2.40
Decrease in Anxiety Score
Anxiety score in the group after treatment.
6.83 ± 2.97
Decrease in Depression Score
Depression score in the group after treatment.
2,791
Fecal Metabolites Identified
Total metabolites identified in the study.

Key figures

Figure 1
Recruitment and group assignment of participants in a study on anxiety and
Sets up clear participant groups to evaluate probiotic effects on anxiety and mental health symptoms
fimmu-14-1158137-g001
  • Panel A
    230 participants assessed for eligibility; 140 excluded due to declining or exclusion criteria
  • Panel B
    90 participants enrolled and divided into anxiety and depression group (60) and healthy subjects group (30)
  • Panel C
    Anxiety and depression group split into probiotic group (PB, n=30) and group (P, n=30)
  • Panel D
    Healthy subjects assigned to HP group (kept diet habits, n=30)
Figure 2
Gut microbial diversity and species overlap in normal control, , and groups
Highlights higher gut microbial diversity and distinct species composition in placebo group compared to normal controls and probiotic-treated subjects
fimmu-14-1158137-g002
  • Panel A
    Chao1 and Shannon indices measuring gut microbiota diversity in HP (normal control), P (placebo), and PB (probiotic JYLP-326) groups; P group shows significantly higher diversity indices than HP group (p < 0.05)
  • Panel B
    (Principal Coordinates Analysis) plot showing gut microbiota community clustering for HP, P, and PB groups; P group appears to have a distinct cluster compared to HP and PB groups
  • Panel C
    showing shared and unique gut microbial species among HP, P, and PB groups; each group has unique species with some overlap
Figure 3
Gut bacterial composition at and levels in normal control, , and JYLP-326 groups
Highlights higher and Roseburia abundance in placebo versus control, showing gut microbiota shifts with anxiety and treatment
fimmu-14-1158137-g003
  • Panels A
    of gut bacteria at the phylum level across HP (normal control), P (placebo), and PB (JYLP-326) groups; Firmicutes abundance is significantly higher in the placebo group compared to normal control
  • Panels A
    Relative abundance plots for Actinobacteria, Bacteroidetes, and Proteobacteria show no statistically significant differences among HP, P, and PB groups
  • Panels B
    Relative abundance of gut bacteria at the genus level across HP, P, and PB groups; Roseburia abundance is significantly higher in the placebo group compared to normal control
  • Panels B
    Relative abundance plots for Bacteroides, Prevotella, and Bifidobacterium show no statistically significant differences among HP, P, and PB groups
Figure 4
Fecal metabolite profiles and metabolite types in normal control, P, and PB groups
Highlights distinct fecal metabolite profiles and dominant lipid-related compounds across groups in test anxiety study
fimmu-14-1158137-g004
  • Panel A
    plot of fecal metabolites in ESI+ mode showing sample distribution for HP (green squares), P (purple circles), PB (pink triangles), and QC (yellow diamonds)
  • Panel B
    PCA plot of fecal metabolites in ESI- mode showing sample distribution for HP (green squares), P (purple circles), PB (pink triangles), and QC (yellow diamonds)
  • Panel C
    Pie chart showing the proportion of identified fecal metabolite , with lipids and lipid-like molecules as the largest group (28.038%)
Figure 5
and their pathway enrichment in test anxious college groups
Highlights distinct metabolic pathway enrichments linked to anxiety and treatment effects in college students
fimmu-14-1158137-g005
  • Panels A and B
    Venn diagrams showing overlap and unique differential metabolites among PB vs HP, P vs HP, and PB vs P groups in ESI+ (A) and ESI- (B) modes, totaling 200 metabolites
  • Panel C
    Scatter plot of KEGG pathway enrichment for differential metabolites with dot size representing metabolite number and color indicating statistical significance
1 / 5

Full Text

What this is

  • This research evaluates the effects of the probiotic JYLP-326 on anxiety, depression, and insomnia in anxious college students.
  • Sixty anxious students were randomly assigned to receive either JYLP-326 or a placebo for three weeks.
  • The study also analyzed changes in gut microbiota and fecal metabolites to understand the underlying mechanisms.

Essence

  • JYLP-326 significantly alleviated anxiety, depression, and insomnia symptoms in anxious college students, potentially through gut microbiota modulation.

Key takeaways

  • JYLP-326 reduced anxiety and depression scores in students facing exam stress. Compared to the placebo group, the probiotic group showed significant decreases in anxiety and depression symptoms after treatment.
  • The gut microbiota diversity was affected by test anxiety. JYLP-326 administration helped restore the diversity of gut microbiota disturbed by stress, indicating its potential role in gut-brain interactions.
  • Fecal metabolites were significantly altered by JYLP-326 treatment. The probiotic reversed the levels of several metabolites associated with anxiety, suggesting a metabolic pathway linking gut health and mental well-being.

Caveats

  • The study's sample size was limited to 60 anxious students, which may affect the generalizability of the findings to broader populations.
  • The exact mechanisms by which JYLP-326 influences gut microbiota and mental health remain unclear and require further investigation.

Definitions

  • psychobiotic: Probiotics that have a positive effect on mental health by influencing the gut microbiota.

Simplified

Funding

Competing interests

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free